Physician profile
Matthew Ng
NPI 1033470240
$9,602.80
in general payments reported to CMS, 2019-2025
27 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,883 · 2020: $314 · 2021: $2,649 · 2022: $1,011 · 2023: $474 · 2024: $1,127 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,966 · Honoraria: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,966.15 |
| Honoraria | $780.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,366.19 | 2019-2022 | |
| Davol INC. | $1,231.66 | 2019-2025 | Arista Ah Flexitip |
| Thd America, INC. | $789.10 | 2020-2025 | |
| Axonics, INC. | $394.80 | 2022-2024 | Axonics |
| Integra Lifesciences Corporation | $289.03 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Takeda Pharmaceuticals U.S.A., INC. | $284.67 | 2021-2025 | Gattex |
| Medtronic, INC. | $281.34 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $245.53 | 2019-2024 | Exparel |
| Boston Scientific Corporation | $229.20 | 2022-2025 | Spyglass |
| Abbvie INC. | $207.47 | 2022-2024 | |
| Ethicon US, LLC | $193.29 | 2021-2023 | Echelon Circular |
| Acera Surgical, INC. | $160.86 | 2025 | Restrata Wound Matrix |
| Conmed Corporation | $150.68 | 2021 | |
| Janssen Scientific Affairs, LLC | $131.27 | 2024 | Tremfya |
| Acell, INC. | $122.23 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $97.72 | 2019 | |
| Kerecis Limited | $64.34 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Braintree Laboratories, INC. | $63.78 | 2020-2021 | |
| Trevena, INC. | $49.56 | 2021 | |
| Baudax Bio INC. | $48.97 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $45.91 | 2025 | Eclipse |
| Cook Medical LLC | $36.21 | 2020 | |
| Potrero Medical, INC. | $33.24 | 2021 | |
| Haemonetics Corporation | $28.54 | 2024 | Teg6s Hemostasis System |
| Astrazeneca Pharmaceuticals LP | $20.13 | 2023 | Andexxa |
| Vertex Pharmaceuticals Incorporated | $20.11 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.